Becker-Haimes, Emily M. https://orcid.org/0000-0002-9922-8667
Brady, Megan
Jamison, Jesslyn
Jager-Hyman, Shari
Reilly, Megan E.
Patel, Esha
Brown, Gregory K.
Mandell, David S.
Oquendo, Maria A.
Funding for this research was provided by:
NIMH (P50 MH127511)
Article History
Received: 6 October 2023
Accepted: 12 November 2023
First Online: 24 November 2023
Declarations
:
: All study procedures were approved by the City of Philadelphia Institutional Review Board (IRB) and the University of Pennsylvania (IRB) in accordance with ethical research guidelines for human subjects. Any modifications to the strategy and outreach materials will be submitted to the IRBs per institution procedures. Any deviations from the protocol or adverse events will be documented and reported. All participants will be provided a copy of documentation of their consent before engaging in any study activities. This report was prepared using the Standard Protocol Items: Recommendations for Interventional Trials 2013 Checklist.
: N/a.
: Dr. Oquendo and Dr. Brown receive royalties from the Research Foundation for Mental Hygiene for the commercial use of the Columbia Suicide Severity Rating Scale. Dr. Oquendo serves as an advisor to Alkermes, St. George’s University, and Fundación Jimenez Diaz; her family owns stock in Bristol Myers Squibb. Dr. Brown serves as an advisor for Oui Therapeutics, LLC, and Psych Hub, LLC. The other authors declare that they have no competing interests.